Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back

This study is currently recruiting participants.

Study NCT00783965 Information provided by National Cancer Institute (NCI)

First Received: October 31, 2008 Last Updated: April 18, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Neoplastic Syndrome
Non-Melanomatous Skin Cancer

Additional conditions recognized in this trial

Basal Cell Nevus Syndrome
Skin Neoplasms
Syndrome

Interventions listed in this trial

tazarotene
placebo

More general drug interventions related to this trial

Dermatologic Agents
Keratolytic Agents
Pharmacologic Actions
Therapeutic Uses

Sponsors listed in this trial

Children's Hospital &Research Center Oakland
National Cancer Institute (NCI)

Back to top of Main Content